See also this year's filing and all EDGAR filings for this company.
PDF Report 0000850693_2011_Allergan_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0000850693, Allergan INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 3,993,700,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 3,034,600,000 |
| 2 | PropertyPlantAndEquipmentNet | 800,600,000 |
| 3 | remainder_Assets | 479,200,000 |
| 4 | LiabilitiesCurrent | 1,528,400,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 2,017,600,000 |
| 9 | ResearchAndDevelopmentExpense | 804,600,000 |
| 10 | remainder_Expenses | 2,004,500,000 |
| 11 | remainder_Revenues | 4,919,400,000 |
| 12 | remainder_NetIncome | -87,800,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 8,308,100,000 |
| 1 | Liabilities | 1,528,400,000 |
| 2 | Expenses | 4,826,700,000 |
| 3 | Revenues | 4,919,400,000 |
| 4 | StockholdersEquity | 6,779,700,000 |
| 5 | NetIncome | 4,900,000 |
| 6 | ComprehensiveNetIncome | 4,900,000 |
| 7 | BaseVar | 9,835,200,000 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 3.01 |
| 9 | EconomicCapitalRatio | 3.69 |